中信证券：医保新政出台 医疗器械迎来行业性投资机遇

Core Insights - The National Healthcare Security Administration (NHSA) has released new guidelines for pricing related to surgical robots and surgical consumables, which is expected to accelerate the promotion and adoption of surgical robots in China [1] - The NHSA indicated that the guidelines will continue to expand in the future, benefiting the overall innovative medical device products [1] - CITIC Securities strongly recommends investors to focus on investment opportunities within the medical industry chain, particularly in the surgical robot sector and its upstream and downstream industries [1] Investment Focus Areas - Emphasis on the surgical robot industry and its related supply chain, including laparoscopic robots, orthopedic robots, and neurosurgical robots [1] - Recommendation to pay attention to high-value consumables in minimally invasive surgery, orthopedics, gastroenterology, cardiovascular, and neurology [1]